These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8515717)

  • 1. The prevalence of oestrogen replacement therapy in South Australia.
    MacLennan AH; MacLennan A; Wilson D
    Maturitas; 1993 May; 16(3):175-83. PubMed ID: 8515717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prevalence of hysterectomy in South Australia.
    MacLennan AH; MacLennan A; Wilson D
    Med J Aust; 1993 Jun; 158(12):807-9. PubMed ID: 8326889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in the use of hormone replacement therapy in South Australia.
    MacLennan AH; Taylor AW; Wilson DH
    Med J Aust; 1995 Apr; 162(8):420-2. PubMed ID: 7746176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and characteristics associated with use of hormone replacement therapy in Britain.
    Moorhead T; Hannaford P; Warskyj M
    Br J Obstet Gynaecol; 1997 Mar; 104(3):290-7. PubMed ID: 9091004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormone replacement therapy: prevalence, compliance and the 'healthy women' notion.
    MacLennan AH; Wilson DH; Taylor AW
    Climacteric; 1998 Mar; 1(1):42-9. PubMed ID: 11907925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Public perceptions and self-reported prevalence of osteoporosis in South Australia.
    Phillipov G; Phillips PJ; Leach G; Taylor AW
    Osteoporos Int; 1998; 8(6):552-6. PubMed ID: 10326060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormone replacement therapy: characteristics of users and non-users in a British general practice cohort identified through computerised prescribing records.
    Lancaster T; Surman G; Lawrence M; Mant D; Vessey M; Thorogood M; Yudkin P; Daly E
    J Epidemiol Community Health; 1995 Aug; 49(4):389-94. PubMed ID: 7650462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health status of users of hormone replacement therapy by hysterectomy status in Western Australia.
    Lambert LJ; Straton JA; Knuiman MW; Bartholomew HC
    J Epidemiol Community Health; 2003 Apr; 57(4):294-300. PubMed ID: 12646547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen replacement therapy. A survey of older women's attitudes.
    Salamone LM; Pressman AR; Seeley DG; Cauley JA
    Arch Intern Med; 1996 Jun; 156(12):1293-7. PubMed ID: 8651837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oestrogen replacement therapy after hysterectomy.
    Seeley T
    BMJ; 1992 Oct; 305(6857):811-2. PubMed ID: 1301029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of Menopausal Hormone Therapy and Bioidentical Hormone Therapy in Australian Women 50 to 69 Years of Age: Results from a National, Cross-Sectional Study.
    Velentzis LS; Banks E; Sitas F; Salagame U; Tan EH; Canfell K
    PLoS One; 2016; 11(3):e0146494. PubMed ID: 27008039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of estrogen or estrogen-progestin hormone therapy use.
    Brett KM; Reuben CA
    Obstet Gynecol; 2003 Dec; 102(6):1240-9. PubMed ID: 14662210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomised comparison of oestrogen versus oestrogen plus progestogen hormone replacement therapy in women with hysterectomy. Medical Research Council's General Practice Research Framework.
    BMJ; 1996 Feb; 312(7029):473-8. PubMed ID: 8597678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormone replacement therapy and risk of non-fatal stroke.
    Pedersen AT; Lidegaard O; Kreiner S; Ottesen B
    Lancet; 1997 Nov; 350(9087):1277-83. PubMed ID: 9357407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utilisation of hormone replacement therapy by women doctors.
    Isaacs AJ; Britton AR; McPherson K
    BMJ; 1995 Nov; 311(7017):1399-401. PubMed ID: 8520274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health status of hormone replacement therapy users and non-users as determined by the SF-36 quality-of-life dimension.
    Wilson DH; Taylor AW; MacLennan AH
    Climacteric; 1998 Mar; 1(1):50-4. PubMed ID: 11907927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Women's health in midlife: the influence of the menopause, social factors and health in earlier life.
    Kuh DL; Wadsworth M; Hardy R
    Br J Obstet Gynaecol; 1997 Aug; 104(8):923-33. PubMed ID: 9255084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormone replacement therapies in women at risk of cardiovascular disease and osteoporosis in South Australia in 1997.
    MacLennan AH; Wilson DH; Taylor AW
    Med J Aust; 1999 Jun; 170(11):524-7. PubMed ID: 10397042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancer and hormone-replacement therapy in the Million Women Study.
    Beral V;
    Lancet; 2003 Aug; 362(9382):419-27. PubMed ID: 12927427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Why do women doctors in the UK take hormone replacement therapy?
    Isaacs AJ; Britton AR; McPherson K
    J Epidemiol Community Health; 1997 Aug; 51(4):373-7. PubMed ID: 9328541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.